AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 3113280 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 29898700 — intervention group
Group type: EXPERIMENTAL
Intervention: Adolescent Haze Related Knowledge Awareness Assessment Scale (AHRKAAS)
Number of subjects: 1100
Study 27192846 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal anaesthesia (SA)
Number of subjects: 67
Study 27192846 — intervention group
Group type: COMPARATOR
Intervention: General anaesthesia (GA)
Number of subjects: 67
Study 24141323 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep Hypothermic Circulatory Arrest (DHCA)
Number of subjects: 37
Study 24141323 — intervention group
Group type: EXPERIMENTAL
Intervention: Antegrade Cerebral Perfusion (ACP)
Number of subjects: 37
Study 24141323 — intervention group
Group type: COMPARATOR
Intervention: Both DHCA and ACP
Number of subjects: 37
Study 24141323 — intervention group
Group type: COMPARATOR
Intervention: Postoperative arterial Pco2
Number of subjects: 37
Study 22273813 — intervention group
Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA
Number of subjects: 313
Study 22273813 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 313
Study 19626326 — intervention group
Group type: EXPERIMENTAL
Intervention: CT colonography with limited bowel preparation (180 ml diatrizoate meglumine, 80 ml barium, 30 mg bisacodyl)
Number of subjects: 173
Study 19626326 — intervention group
Group type: COMPARATOR
Intervention: Colonoscopy with full preparation (4 l of polyethylene glycol solution)
Number of subjects: 173
Study 19626326 — intervention group
Group type: EXPERIMENTAL
Intervention: CT colonography
Number of subjects: 173
Study 19626326 — intervention group
Group type: COMPARATOR
Intervention: Colonoscopy
Number of subjects: 173
Study 18685527 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold drink (4 degrees C)
Number of subjects: 8
Study 16579802 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil (various doses)
Number of subjects: 3098
Study 16579802 — intervention group
Group type: EXPERIMENTAL
Intervention: Flax oil (2.2 g of alpha-linolenic acid per day)
Number of subjects: 3098
Study 16579802 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 3098
Study 12568839 — intervention group
Group type: COMPARATOR
Intervention: 150 IU of Gonal-F
Number of subjects: 124
Study 12568839 — intervention group
Group type: EXPERIMENTAL
Intervention: 225 IU of Gonal-F
Number of subjects: 124
Study 11198497 — intervention group
Group type: EXPERIMENTAL
Intervention: Febrile convulsions after 5 years of age (group 1)
Number of subjects: 239
Study 11198497 — intervention group
Group type: COMPARATOR
Intervention: Febrile convulsions before 5 years of age (group 2)
Number of subjects: 239
Study 8833174 — intervention group
Group type: EXPERIMENTAL
Intervention: Soybean oil plus psyllium fiber (SO + PF)
Number of subjects: 10
Study 8833174 — intervention group
Group type: EXPERIMENTAL
Intervention: Coconut oil plus psyllium fiber (CO + PF)
Number of subjects: 10
Study 8833174 — intervention group
Group type: COMPARATOR
Intervention: Soybean oil diet (SO)
Number of subjects: 10
Study 8833174 — intervention group
Group type: COMPARATOR
Intervention: Coconut oil diet (CO)
Number of subjects: 10
Study 8833174 — intervention group
Group type: EXPERIMENTAL
Intervention: Psyllium fiber supplementation
Number of subjects: 10
Study 1577155 — intervention group
Group type: EXPERIMENTAL
Intervention: i.v. salbutamol treatment (5 micrograms.kg‐1)
Number of subjects: 140
Study 1577155 — intervention group
Group type: EXPERIMENTAL
Intervention: inhaled salbutamol (0.15 mg.kg‐1 x 2)
Number of subjects: 140
Study 1577155 — intervention group
Group type: EXPERIMENTAL
Intervention: theophylline
Number of subjects: 140
Study 1577155 — intervention group
Group type: EXPERIMENTAL
Intervention: terbutaline
Number of subjects: 140
Study 1577155 — intervention group
Group type: EXPERIMENTAL
Intervention: salbutamol
Number of subjects: 140
Study 6515508 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxycillin 1500 mg/d for 2 weeks and 1000 mg/d for 12 weeks thereafter
Number of subjects: 26
Study 6515508 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin stearate 1500 mg/d for 2 weeks and 1000 mg/d for 12 weeks thereafter
Number of subjects: 26
Study 6515508 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 26
Study 31744146 — intervention group
Group type: EXPERIMENTAL
Intervention: Metacognitive Training (MCT), 16 sessions
Number of subjects: 22
Study 31744146 — intervention group
Group type: COMPARATOR
Intervention: Usual treatment (Control)
Number of subjects: 22
Study 31744146 — intervention group
Group type: EXPERIMENTAL
Intervention: Metacognitive Training (MCT)
Number of subjects: 22
Study 29889764 — intervention group
Group type: EXPERIMENTAL
Intervention: Elagolix 150 mg once daily
Number of subjects: 569
Study 29889764 — intervention group
Group type: EXPERIMENTAL
Intervention: Elagolix 200 mg twice daily
Number of subjects: 569
Study 29889764 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 569
Study 27015283 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab 5 mg/kg plus naproxen 1,000 mg/day
Number of subjects: 158
Study 27015283 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus naproxen 1,000 mg/day
Number of subjects: 158
Study 24692050 — intervention group
Group type: EXPERIMENTAL
Intervention: Denosumab
Number of subjects: 41
Study 22584564 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive educational intervention (GI) with six weekly visits
Number of subjects: 47
Study 22584564 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (GC)
Number of subjects: 47
Study 22584564 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive educational intervention (GI)
Number of subjects: 47
Study 22584564 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in fiber intake
Number of subjects: 47
Study 20385376 — intervention group
Group type: EXPERIMENTAL
Intervention: Active T-PEMF
Number of subjects: 0
Study 20385376 — intervention group
Group type: COMPARATOR
Intervention: Sham T-PEMF
Number of subjects: 0
Study 17999650 — intervention group
Group type: EXPERIMENTAL
Intervention: Acid infusion (HCl, 0.1 mol L(‐1))
Number of subjects: 43
Study 17999650 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 43
Study 15814401 — intervention group
Group type: EXPERIMENTAL
Intervention: Contraceptive advice during antenatal period
Number of subjects: 64
Study 15814401 — intervention group
Group type: EXPERIMENTAL
Intervention: Contraceptive advice during postpartum period
Number of subjects: 64
Study 15814401 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of information provided
Number of subjects: 64
Study 15814401 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term contraceptive methods information
Number of subjects: 64
Study 15814401 — intervention group
Group type: EXPERIMENTAL
Intervention: Midwives' training
Number of subjects: 64
Study 15814401 — intervention group
Group type: EXPERIMENTAL
Intervention: Midwives' confidence in knowledge
Number of subjects: 64
Study 15814401 — intervention group
Group type: EXPERIMENTAL
Intervention: Need for comprehensive discussion
Number of subjects: 64
Study 15814401 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular training for midwives
Number of subjects: 64
Study 14589461 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonoperative treatment of neck pain
Number of subjects: 0
Study 14589461 — intervention group
Group type: COMPARATOR
Intervention: Cochrane review methodology
Number of subjects: 0
Study 10511940 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.1 mm TurboSonics tip
Number of subjects: 100
Study 10511940 — intervention group
Group type: COMPARATOR
Intervention: 0.9 mm Aspiration Bypass System (ABS) tip
Number of subjects: 100
Study 7853599 — intervention group
Group type: EXPERIMENTAL
Intervention: Directional atherectomy
Number of subjects: 73
Study 7853599 — intervention group
Group type: COMPARATOR
Intervention: Balloon angioplasty
Number of subjects: 73
Study 1660823 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (1.5 g in five or six doses over 5 days)
Number of subjects: 0
Study 1660823 — intervention group
Group type: COMPARATOR
Intervention: Erythromycin (10 g in 40 doses over 10 days)
Number of subjects: 0
Study 1660823 — intervention group
Group type: COMPARATOR
Intervention: Amoxycillin (15 g in 30 doses over 10 days)
Number of subjects: 0
Study 7138752 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-acting propranolol
Number of subjects: 10
Study 7138752 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-acting propranolol and bendrofluazide
Number of subjects: 10
Study 7138752 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined formulation of long-acting propranolol/bendrofluazide (Inderex)
Number of subjects: 10
Study 7138752 — intervention group
Group type: COMPARATOR
Intervention: All three preparations (LA propranolol, LA propranolol and bendrofluazide, combined formulation)
Number of subjects: 10
Study 7138752 — intervention group
Group type: COMPARATOR
Intervention: LA propranolol alone
Number of subjects: 10
Study 7138752 — intervention group
Group type: COMPARATOR
Intervention: Bendrofluazide in two preparations
Number of subjects: 10
Study 31422087 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrathin-strut cobalt-chromium Orsiro sirolimus-eluting stent (SES)
Number of subjects: 3514
Study 31422087 — intervention group
Group type: COMPARATOR
Intervention: Durable-polymer thin-strut cobalt-chromium Resolute Integrity zotarolimus-eluting stent (ZES)
Number of subjects: 3514
Study 31422087 — intervention group
Group type: EXPERIMENTAL
Intervention: Very-thin-strut platinum-chromium Synergy everolimus-eluting stent
Number of subjects: 3514
Study 30132786 — intervention group
Group type: EXPERIMENTAL
Intervention: (-)-OSU6162 15 mg twice daily for 4 weeks, then 30 mg twice daily for 4 weeks, then 45 mg twice daily for 4 weeks
Number of subjects: 30
Study 30132786 — intervention group
Group type: EXPERIMENTAL
Intervention: (-)-OSU6162
Number of subjects: 30
Study 27725493 — intervention group
Group type: EXPERIMENTAL
Intervention: Prasugrel 20 mg
Number of subjects: 78
Study 27725493 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel 300 mg
Number of subjects: 78
Study 24381285 — intervention group
Group type: EXPERIMENTAL
Intervention: Neural representations formed at very early (180 ms) stages of encoding during recollection of images depicting faces and scenes.
Number of subjects: 0
Study 24381285 — intervention group
Group type: EXPERIMENTAL
Intervention: Recollection process occurring 500 ms after the onset of a cue that prompts recollection.
Number of subjects: 0
Study 21822764 — intervention group
Group type: EXPERIMENTAL
Intervention: The Transporters DVD intervention for 3 weeks
Number of subjects: 0
Study 21822764 — intervention group
Group type: EXPERIMENTAL
Intervention: The Transporters DVD intervention
Number of subjects: 0
Study 21822764 — intervention group
Group type: COMPARATOR
Intervention: Control group (alternate DVD)
Number of subjects: 0
Study 21822764 — intervention group
Group type: COMPARATOR
Intervention: Thomas the Tank Engine condition
Number of subjects: 0
Study 20374400 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-generated dosing group (CGD)
Number of subjects: 307
Study 20374400 — intervention group
Group type: COMPARATOR
Intervention: Standard management group (SM)
Number of subjects: 307
Study 17666020 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mug vitamin K once daily
Number of subjects: 200
Study 17666020 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 15087989 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 15
Study 15087989 — intervention group
Group type: COMPARATOR
Intervention: Thiopental
Number of subjects: 15
Study 11476013 — intervention group
Group type: EXPERIMENTAL
Intervention: silica‐based tartar control whitening dentifrice
Number of subjects: 187
Study 11476013 — intervention group
Group type: COMPARATOR
Intervention: marketed regular dentifrice control
Number of subjects: 187
Study 9736817 — intervention group
Group type: EXPERIMENTAL
Intervention: Successful kidney transplantation
Number of subjects: 125
Study 9736817 — intervention group
Group type: COMPARATOR
Intervention: CAPD (Continuous Ambulatory Peritoneal Dialysis)
Number of subjects: 125
Study 9736817 — intervention group
Group type: COMPARATOR
Intervention: Hemodialysis
Number of subjects: 125
Study 8002535 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzodiazepine (1.5 mg lorazepam)
Number of subjects: 7
Study 8002535 — intervention group
Group type: COMPARATOR
Intervention: Placebo (gelatin)
Number of subjects: 7
Study 2907669 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg almitrine bismethylate
Number of subjects: 7
Study 2907669 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 30300051 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback intervention group
Number of subjects: 48
Study 30300051 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 48
Study 28732324 — intervention group
Group type: EXPERIMENTAL
Intervention: FEC-Doc (taxane-anthracycline based chemotherapy)
Number of subjects: 170
Study 26745107 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid-Based Cytology (LBC)
Number of subjects: 23030
Study 26745107 — intervention group
Group type: COMPARATOR
Intervention: Conventional Cytology (CC)
Number of subjects: 23030
Study 23427334 — intervention group
Group type: EXPERIMENTAL
Intervention: Polydextrose (PDX) at a dose of 20 g/d
Number of subjects: 36
Study 23427334 — intervention group
Group type: EXPERIMENTAL
Intervention: Soluble corn fiber (SCF) at a dose of 20 g/d
Number of subjects: 36
Study 23427334 — intervention group
Group type: EXPERIMENTAL
Intervention: Polydextrose (PDX)
Number of subjects: 36
Study 23427334 — intervention group
Group type: EXPERIMENTAL
Intervention: Soluble corn fiber (SCF)
Number of subjects: 36
Study 23427334 — intervention group
Group type: EXPERIMENTAL
Intervention: Polydextrose (PDX) and Soluble corn fiber (SCF)
Number of subjects: 36
Study 22074749 — intervention group
Group type: EXPERIMENTAL
Intervention: OPPERA participants (185 with TMD)
Number of subjects: 3481
Study 22074749 — intervention group
Group type: COMPARATOR
Intervention: Controls (1,633 without TMD)
Number of subjects: 3481
Study 19486452 — intervention group
Group type: EXPERIMENTAL
Intervention: roxatidine
Number of subjects: 120
Study 19486452 — intervention group
Group type: EXPERIMENTAL
Intervention: rabeprazole
Number of subjects: 120
Study 19486452 — intervention group
Group type: EXPERIMENTAL
Intervention: lansoprazole
Number of subjects: 120
Study 15213026 — intervention group
Group type: EXPERIMENTAL
Intervention: Eicosapentaenoic acid (EPA)
Number of subjects: 33
Study 15213026 — intervention group
Group type: EXPERIMENTAL
Intervention: Docosahexaenoic acid (DHA)
Number of subjects: 33
Study 15213026 — intervention group
Group type: COMPARATOR
Intervention: Safflower oil (SAF)
Number of subjects: 33
Study 15213026 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA
Number of subjects: 33
Study 15213026 — intervention group
Group type: EXPERIMENTAL
Intervention: EPA
Number of subjects: 33
Study 10029956 — intervention group
Group type: EXPERIMENTAL
Intervention: Keyboard A (n = 10)
Number of subjects: 20
Study 10029956 — intervention group
Group type: COMPARATOR
Intervention: Keyboard B (n = 10)
Number of subjects: 20
Study 8838821 — intervention group
Group type: EXPERIMENTAL
Intervention: Rice-based oral rehydration solution (50 g/l)
Number of subjects: 48
Study 8838821 — intervention group
Group type: COMPARATOR
Intervention: Glucose-based WHO/UNICEF-recommended ORS
Number of subjects: 48
Study 2248588 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic treatment following removal of the foreign body
Number of subjects: 0
Study 2248588 — intervention group
Group type: COMPARATOR
Intervention: Placebo (sterile saline)
Number of subjects: 0
Study 6998553 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose methotrexate-citrovorum factor rescue plus cyclophosphamide (MECY)
Number of subjects: 0
Study 6998553 — intervention group
Group type: COMPARATOR
Intervention: 5-fluorouracil plus cyclophosphamide (FUCY)
Number of subjects: 0
Study 6998553 — intervention group
Group type: COMPARATOR
Intervention: Corynebacterium parvum immunotherapy
Number of subjects: 0
Study 30888329 — intervention group
Group type: EXPERIMENTAL
Intervention: MyLung mobile health app
Number of subjects: 30
Study 28377297 — intervention group
Group type: EXPERIMENTAL
Intervention: 48h TTM at 33 ±1°C
Number of subjects: 105
Study 28377297 — intervention group
Group type: COMPARATOR
Intervention: 24h TTM at 33 ±1°C
Number of subjects: 105
Study 26644527 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptom monitoring via tablet computers
Number of subjects: 766
Study 24324046 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol-based treatment
Number of subjects: 6549
Study 24324046 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine-based treatment
Number of subjects: 6549
Study 24324046 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine-based treatment (NT-proBNP below median)
Number of subjects: 6549
Study 21995319 — intervention group
Group type: EXPERIMENTAL
Intervention: Affirmation of afterlife belief
Number of subjects: 0
Study 21995319 — intervention group
Group type: COMPARATOR
Intervention: Support of atheistic worldview
Number of subjects: 0
Study 19180071 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive Lifestyle Intervention (ILI)
Number of subjects: 5145
Study 19180071 — intervention group
Group type: COMPARATOR
Intervention: Diabetes Support and Education (DSE)
Number of subjects: 5145
Study 19180071 — intervention group
Group type: EXPERIMENTAL
Intervention: Orlistat (as a toolbox option)
Number of subjects: 5145
Study 17883910 — intervention group
Group type: EXPERIMENTAL
Intervention: Olopatadine 0.2%
Number of subjects: 90
Study 17883910 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 15973255 — intervention group
Group type: EXPERIMENTAL
Intervention: Applied relaxation training with routine prenatal care
Number of subjects: 110
Study 15973255 — intervention group
Group type: COMPARATOR
Intervention: Routine prenatal care only
Number of subjects: 110
Study 11753054 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous transfusion combining ANH with ICS
Number of subjects: 145
Study 11753054 — intervention group
Group type: COMPARATOR
Intervention: Standard transfusion practice (Allogeneic transfusion)
Number of subjects: 145
Study 9850427 — intervention group
Group type: EXPERIMENTAL
Intervention: New amitriptyline tablet formulation (amitriptylin 25 von ct)
Number of subjects: 18
Study 9850427 — intervention group
Group type: COMPARATOR
Intervention: Reference preparation (28.3 mg amitriptyline hydrochloride)
Number of subjects: 18
Study 7853069 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician intervention providing educational demonstration of anxiety and reporting system for summarizing anxiety symptom levels and functioning status.
Number of subjects: 573
Study 7853069 — intervention group
Group type: COMPARATOR
Intervention: Control arm (physicians not receiving the intervention).
Number of subjects: 573
Study 2679853 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose metoclopramide with dexamethasone and lorazepam
Number of subjects: 81
Study 2679853 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone and lorazepam
Number of subjects: 81
Study 2679853 — intervention group
Group type: COMPARATOR
Intervention: Oral dexamethasone alone
Number of subjects: 81
Study 2679853 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone and metoclopramide
Number of subjects: 81
Study 31562827 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% RSFP
Number of subjects: 216
Study 31562827 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5% RSFP
Number of subjects: 216
Study 31562827 — intervention group
Group type: EXPERIMENTAL
Intervention: 12.5% RSFP
Number of subjects: 216
Study 31562827 — intervention group
Group type: EXPERIMENTAL
Intervention: RSFP-supplemented diets
Number of subjects: 216
Study 31562827 — intervention group
Group type: EXPERIMENTAL
Intervention: RSFP-supplemented diet
Number of subjects: 216
Study 30311085 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 mg/mL TBO
Number of subjects: 56
Study 30311085 — intervention group
Group type: EXPERIMENTAL
Intervention: Diode laser (633 nm, 20 mW, 6 J/cm2)
Number of subjects: 56
Study 30311085 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of TBO and diode laser
Number of subjects: 56
Study 30311085 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 56
Study 29097293 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI) using everolimus‐eluting stents
Number of subjects: 1788
Study 29097293 — intervention group
Group type: COMPARATOR
Intervention: Coronary artery bypass graft (CABG)
Number of subjects: 1788
Study 29097293 — intervention group
Group type: EXPERIMENTAL
Intervention: Both PCI and CABG
Number of subjects: 1788
Study 26438556 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser acupuncture (LA) at the Yintang point, 0.3 J of energy applied for 30 seconds, 2 minutes before heel lancing.
Number of subjects: 42
Study 26438556 — intervention group
Group type: COMPARATOR
Intervention: Oral sucrose, 0.5 mL of 24% sucrose administered orally via syringe, 2 minutes before heel lancing.
Number of subjects: 42
Study 23750463 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonally focused therapy-cognitive behavioral analysis system of psychotherapy (CBASP)
Number of subjects: 248
Study 23750463 — intervention group
Group type: COMPARATOR
Intervention: Time-matched health and wellness control (HW)
Number of subjects: 248
Study 21242864 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral balloon kyphoplasty
Number of subjects: 49
Study 21242864 — intervention group
Group type: COMPARATOR
Intervention: Bilateral balloon kyphoplasty
Number of subjects: 49
Study 20329605 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Sanmiao Powder (SMP)
Number of subjects: 94
Study 20329605 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (Control)
Number of subjects: 94
Study 17094160 — intervention group
Group type: EXPERIMENTAL
Intervention: Partners' anxiety
Number of subjects: 96
Study 17094160 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceptions of relationship quality from women with breast cancer and their partners
Number of subjects: 96
Study 17094160 — intervention group
Group type: EXPERIMENTAL
Intervention: Women's anxiety
Number of subjects: 96
Study 15240608 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone replacement (Sustanon 100)
Number of subjects: 27